(Q40752002)

23 September 2017

New 2,N6-disubstituted adenosines: potent and selective A1 adenosine receptor agonists (English)

1 reference

23 September 2017

Sally A Hutchinson

1

1 reference

23 September 2017

Stephen P Baker

series ordinal

2

1 reference

23 September 2017

Peter J Scammells

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Bioorganic & Medicinal Chemistry

23 September 2017

1 reference

23 September 2017

10

1 reference

23 September 2017

4

1 reference

23 September 2017

1115-1122

1 reference

Adenosine receptors: new opportunities for future drugs.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Ischemic preconditioning: from basic mechanisms to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Adenosine receptor ligands-recent developments part I. Agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900384-4

7 January 2021

10.1016/S0968-0896(01)00384-4

Identifiers

DOI

1 reference

23 September 2017

1 reference